DK169336B1 - 1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser - Google Patents

1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser Download PDF

Info

Publication number
DK169336B1
DK169336B1 DK551487A DK551487A DK169336B1 DK 169336 B1 DK169336 B1 DK 169336B1 DK 551487 A DK551487 A DK 551487A DK 551487 A DK551487 A DK 551487A DK 169336 B1 DK169336 B1 DK 169336B1
Authority
DK
Denmark
Prior art keywords
compound
hydroxybutyl
methylxanthine
alkyl group
hydroxypropyl
Prior art date
Application number
DK551487A
Other languages
Danish (da)
English (en)
Other versions
DK551487D0 (da
DK551487A (da
Inventor
Rene Fumeaux
Georges Philippossian
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of DK551487D0 publication Critical patent/DK551487D0/da
Publication of DK551487A publication Critical patent/DK551487A/da
Application granted granted Critical
Publication of DK169336B1 publication Critical patent/DK169336B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK551487A 1986-10-27 1987-10-21 1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser DK169336B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4253/86A CH670090A5 (xx) 1986-10-27 1986-10-27
CH425386 1986-10-27

Publications (3)

Publication Number Publication Date
DK551487D0 DK551487D0 (da) 1987-10-21
DK551487A DK551487A (da) 1988-04-28
DK169336B1 true DK169336B1 (da) 1994-10-10

Family

ID=4272668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK551487A DK169336B1 (da) 1986-10-27 1987-10-21 1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser

Country Status (13)

Country Link
EP (1) EP0269841B1 (xx)
JP (1) JP2527769B2 (xx)
KR (1) KR930010559B1 (xx)
AT (1) ATE82289T1 (xx)
AU (1) AU604767B2 (xx)
CA (1) CA1296001C (xx)
CH (1) CH670090A5 (xx)
DE (1) DE3782619T2 (xx)
DK (1) DK169336B1 (xx)
ES (1) ES2043631T3 (xx)
GR (1) GR3006223T3 (xx)
IL (1) IL84266A (xx)
ZA (1) ZA877851B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
DE4316576A1 (de) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Also Published As

Publication number Publication date
IL84266A (en) 1992-02-16
EP0269841B1 (fr) 1992-11-11
ES2043631T3 (es) 1994-01-01
GR3006223T3 (xx) 1993-06-21
IL84266A0 (en) 1988-03-31
ZA877851B (en) 1988-04-22
KR930010559B1 (ko) 1993-10-28
EP0269841A1 (fr) 1988-06-08
AU7998087A (en) 1988-04-28
CH670090A5 (xx) 1989-05-12
DE3782619D1 (de) 1992-12-17
ATE82289T1 (de) 1992-11-15
DK551487D0 (da) 1987-10-21
DE3782619T2 (de) 1993-04-22
KR880005131A (ko) 1988-06-28
DK551487A (da) 1988-04-28
AU604767B2 (en) 1991-01-03
CA1296001C (en) 1992-02-18
JPS63122683A (ja) 1988-05-26
JP2527769B2 (ja) 1996-08-28

Similar Documents

Publication Publication Date Title
CN100497336C (zh) 制备黄嘌呤磷酸二酯酶v抑制剂及其前体的方法
US4923872A (en) Analogues of pyrrolo[3,2d]pyrimidin-4-ones
EP0159264B1 (en) Antiviral compounds
US4287188A (en) Purine derivatives
EP0207901B1 (en) Antianaphylactic and antibronchospastic n-benzhydryldiazacycloalkylalkananilides
US3995039A (en) Pyrazolo [1,5-a] [1,3,5] triazines
JPH0692407B2 (ja) Ｎ▲上６▼−ジ置換プリン誘導体、その製法及び該誘導体を含有するアレルギ−性疾患の治療剤
CS390691A3 (en) Olefinic 1h-imidazo-(4,5-c)quinolin-4-amines
EP0269378A1 (en) Quinazolinone derivative and processes for preparing the same
EP0269574A2 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
NO175592B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive xantiner
IE42282B1 (en) Purine compounds and salts thereof
Jacobs et al. Synthesis of SQ-32,829, a new nucleoside antiviral agent
GB2075505A (en) Di-and tri-substituted xanthines
DK169705B1 (da) 9-Deazaguaniner, farmaceutisk komposition indeholdende en sådan forbindelse, en sådan forbindelse til terapeutisk anvendelse, anvendelse af en sådan forbindelse til fremstilling af en farmaceutisk komposition og fremgangsmåde til forbindelsernes fremstilling, samt forbindelse til mellemproduktanvendelse
EP0156559A2 (en) 8-Substituted guanine derivatives
HU197749B (en) Process for producing /3,4-d/pyrimidine derivatives and pharmaceutical compositions comprising these compounds as active ingredient
EP0178178A2 (en) Purine derivatives
DK169336B1 (da) 1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser
Guillarme et al. Rapid access to acyclic nucleosides via conjugate addition
US5002950A (en) 7-deazaguanines as immunomodulators
GB1599518A (en) 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof
NZ194228A (en) 2-(1,4-diazacycloalk-1-yl)-4-(morpholino or thiomorpholino)-8-substituted pyrimido(4,5-b)pyrimidines
US5338741A (en) 1-hydroxyalkylxanthines and medicaments containing them
AU630223B2 (en) Substituted purines for use in the treatment of viruses

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PBP Patent lapsed